An adult with recurrent atypical teratoid rhabdoid tumor of the spine

Reference

• WHO Classification of tumors Editorial Board. Central Nervous System tumors. International Agency for Research on Cancer, Lyon, France. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Central-Nervous-System-Tumours-2021
   Google Scholar
• Li L, Patel M, Nguyen HS, Doan N, Sharma A, Maiman D. Primary atypical teratoid/rhabdoid tumor of the spine in an adult patient. Surgl. Neurol. Int. 7, 27 (2016).
   PubMedGoogle Scholar
• Chao MF, Su Y-F, Jaw T-S, Chiou S-S, Lin C-H. Atypical teratoid/rhabdoid tumor of lumbar spine in a toddler child. Spinal Cord Ser. Cases. 3, 16026 (2017).
   PubMedGoogle Scholar
• Amit A, Vats A, Shoakazemi A, Herron B, McCarthy A, McConnell RS. Dumbell atypical teratoid/rhabdoid tumour (AT/RT) of the cervical spine. Br. J. Neurosurg. 34(3), 339–341 (2020).
   PubMed Web of Science ®Google Scholar
• Liebigt S, Florschütz A, Arndt N, Stock K, Renner C. Atypical teratoid/rhabdoid tumor of the pineal region in a young adult male patient: case report and review of the literature. J. Neurol. Surg. A Cent Eur. Neurosurg. 78(1), 92–98 (2017).
   PubMedGoogle Scholar
• Broggi G, Gianno F, Shemy DT et al. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases. J. Neurooncol. 157(1), 1–14 (2022).
   PubMed Web of Science ®Google Scholar
• Zarovnaya EL, Pallatroni HF, Hug EB et al. Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J. Neurooncol. 84(1), 49–55 (2007).
   PubMed Web of Science ®Google Scholar
• Karim A, Shaikhyzada K, Suleimenova A, Ibraimov B, Nurgaliev D, Poddighe D. Case report: atypical teratoid/rhabdoid tumor of the lateral ventricle in a male adolescent (case-based review and diagnostic challenges in developing countries). Front. Oncol. 12, 985862 (2022).
   PubMed Web of Science ®Google Scholar
• Truitt G, Gittleman H, Leece R et al. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT. J. Neurooncol. 144(1), 53–63 (2019).
   PubMed Web of Science ®Google Scholar
• Peng AJ, Fan SC, Chen YX et al. Atypical teratoid/rhabdoid tumor in adult: case series and an integrated survival analysis. Br. J. Neurosurg. doi:10.1080/02688697.2021.1885620 (2021) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Riley DS, Barber MS, Kienle GS et al. CARE guidelines for case reports: explanation and elaboration document. J. Clin. Epidemiol. 89, 218–235 (2017).
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131(6), 803–820 (2016).
   PubMed Web of Science ®Google Scholar
• Rauschenbach L. Spinal cord tumor microenvironment. Adv. Exp. Med. Biol. 1226, 97–109 (2020).
   PubMed Web of Science ®Google Scholar
• Karsy M, Guan J, Sivakumar W, Neil JA, Schmidt MH, Mahan MA. The genetic basis of intradural spinal tumors and its impact on clinical treatment. Neurosurg Focus. 39(2), E3 (2015).
   PubMed Web of Science ®Google Scholar
• Rosemberg S, Menezes Y, Sousa MR, Plese P, Ciquini O. Primary malignant rhabdoid tumor of the spinal dura. Clin. Neuropathol. 13(4), 221–224 (1994).
   PubMed Web of Science ®Google Scholar
• Moeller KK, Coventry S, Jernigan S, Moriarty TM. Atypical teratoid/rhabdoid tumor of the spine. Am. J. Neuroradiol. 28(3), 593–595 (2007).
   PubMed Web of Science ®Google Scholar
• Chan V, Marro A, Findlay JM, Schmitt LM, Das S. A systematic review of atypical teratoid rhabdoid tumor in adults. Front. Oncol. 8, 567 (2018).
   PubMed Web of Science ®Google Scholar
• Ginn KF, Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol. 2, 114 (2012).
   PubMedGoogle Scholar
• Major K, Daggubati LC, Mau C, Zacharia B, Glantz M, Pu C. Sellar atypical teratoid/rhabdoid tumors (AT/RT): a systematic review and case illustration. Cureus. 14(7), e26838 (2022).
   PubMed Web of Science ®Google Scholar
• Park M, Han JW, Hahn SM et al. Atypical teratoid/rhabdoid tumor of the central nervous system in children under the age of 3 years. Cancer Res. Treat. 53(2), 378–388 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang C, Li H. Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors. Pediatr Investig. 6, 111–122 (2022).
   PubMedGoogle Scholar
• Ren Y-M, Wu X, You C, Zhang Y-K, Li Q, Ju Y. Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients. Childs Ner. Syst. 34(4), 627–638 (2017).
   PubMed Web of Science ®Google Scholar
• Torchia J, Golbourn B, Feng S et al. Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell. 30(6), 891–908 (2016).
   PubMed Web of Science ®Google Scholar
• Cash T, Jonus HC, Tsvetkova M et al. A Phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatr. Blood Cancer 70(8), e30405 (2023).
   PubMed Web of Science ®Google Scholar
• Epizyme, Inc. A Phase I study of the EZH2 inhibitor tazemetostat in pediatric subjects with relapsed or refractory INI1-negative tumors or synovial sarcoma. clinicaltrials.gov, Bethesda, MD, USA (2021). https://classic.clinicaltrials.gov/ct2/show/NCT02601937
   Google Scholar
• DeWire MD, Fuller C, Campagne O et al. A Phase I and surgical study of ribociclib and everolimus in children with recurrent or refractory malignant brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res. 27(9), 2442–2451 (2021).
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. A Phase I/II study of tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients With Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors. clinicaltrials.gov, Bethesda, MD, USA (2023). https://clinicaltrials.gov/ct2/show/NCT05286801
   Google Scholar
• Ai L, Chen J, Yan H et al. Research status and outlook of PD-1/PD-L1 inhibitors for cancer therapy. Drug Des Devel Ther. 14, 3625–3649 (2020).
   PubMed Web of Science ®Google Scholar